{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:44:46Z","timestamp":1777131886859,"version":"3.51.4"},"reference-count":236,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116543","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:20:04Z","timestamp":1775600404000},"page":"116543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antimicrobial peptides in malaria and tuberculosis management: a systematic review of emerging evidence"],"prefix":"10.1016","volume":"179","author":[{"given":"Neha Sylvia","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Gorki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod K.","family":"Avti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"280","key":"10.1016\/j.intimp.2026.116543_bb0005","article-title":"Ethanol extract of Bergenia ciliata (Haw.) Sternb. (rhizome) impedes the propagation of the malaria parasite","volume":"2021","author":"Gorki","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116543_bb0010","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/med.21542","article-title":"Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era","volume":"39","author":"Wang","year":"2019","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0015","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1016\/j.cub.2015.11.017","article-title":"Antimicrobial peptides","volume":"26","author":"Zhang","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.intimp.2026.116543_bb0020","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3389\/fimmu.2017.01320","article-title":"Antimicrobial peptides as biologic and immunotherapeutic agents against cancer: A comprehensive overview","volume":"8","author":"Roudi","year":"2017","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116543_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2026.116543_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnins.2017.00073","article-title":"Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design","volume":"11","author":"Li","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2026.116543_bb0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fphar.2018.00281","article-title":"Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds","volume":"9","author":"Pfalzgraff","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116543_bb0040","first-page":"3919","article-title":"The antimicrobial peptides and their potential clinical applications","volume":"11","author":"Lei","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb0045","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.3390\/ijms25094870","article-title":"Antimicrobial peptides towards clinical application-a long history to be concluded","volume":"25","author":"Cresti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116543_bb0050","series-title":"Tuberculosis. Available at","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.intimp.2026.116543_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1359-6446(05)03626-3","article-title":"New drug candidates and therapeutic targets for tuberculosis therapy","volume":"11","author":"Zhang","year":"2006","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The future of peptide-based drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"issue":"26","key":"10.1016\/j.intimp.2026.116543_bb0065","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1002\/anie.201101740","article-title":"The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease","volume":"50","author":"Schmitt","year":"2011","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb0070","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1128\/AAC.01667-10","article-title":"Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis","volume":"55","author":"Kapoor","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.intimp.2026.116543_bb0075","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1021\/acs.jnatprod.5b00266","article-title":"Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity","volume":"78","author":"Daletos","year":"2015","journal-title":"J. Nat. Prod."},{"issue":"7535","key":"10.1016\/j.intimp.2026.116543_bb0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"Erratum: A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2026.116543_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/psc.3428","article-title":"Discovery, synthesis, and optimization of teixobactin, a novel antibiotic without detectable bacterial resistance","volume":"28","author":"Qi","year":"2022","journal-title":"J. Pept. Sci."},{"issue":"24","key":"10.1016\/j.intimp.2026.116543_bb0090","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1128\/JB.02243-14","article-title":"Characterization of a novel plasmid-borne thiopeptide gene cluster in Staphylococcus epidermidis strain 115","volume":"196","author":"Bennallack","year":"2014","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.intimp.2026.116543_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tube.2016.07.011","article-title":"Micrococcin P1 \u2013 A bactericidal thiopeptide active against Mycobacterium tuberculosis","volume":"100","author":"Degiacomi","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.intimp.2026.116543_bb0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41570-021-00313-1","article-title":"Towards the sustainable discovery and development of new antibiotics","volume":"5","author":"Miethke","year":"2021","journal-title":"Nat Rev Chem."},{"issue":"5","key":"10.1016\/j.intimp.2026.116543_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01825-23","article-title":"In vitro and intracellular activities of novel thiopeptide derivatives against macrolide-susceptible and macrolide-resistant Mycobacterium avium complex","volume":"11","author":"Park","year":"2023","journal-title":"Microbiol. Spectrum"},{"issue":"6239","key":"10.1016\/j.intimp.2026.116543_bb0110","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.aaa4690","article-title":"M\u00fcller R. Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins","volume":"348","author":"Kling","year":"2015","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.intimp.2026.116543_bb0115","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chembiol.2015.08.002","article-title":"New Griselimycins for Treatment of Tuberculosis","volume":"22","author":"Holzgrabe","year":"2015","journal-title":"Chem. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116543_bb0120","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1099\/mic.0.000316","article-title":"Laterosporulin10: a novel defensin like Class IId bacteriocin from Brevibacillus sp. strain SKDU10 with inhibitory activity against microbial pathogens","volume":"162","author":"Baindara","year":"2016","journal-title":"Microbiology (Reading)."},{"issue":"3","key":"10.1016\/j.intimp.2026.116543_bb0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/molecules25030485","article-title":"Identification and Characterization of pantocin wh-1, a Novel Cyclic Polypeptide Produced by Pantoea dispersa W18","volume":"25","author":"Teng","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","article-title":"Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2","volume":"21","author":"Gavrish","year":"2014","journal-title":"Chem. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ja.2007.48","article-title":"Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171","volume":"60","author":"Iwatsuki","year":"2007","journal-title":"J Antibiot (Tokyo)."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0140","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1038\/s41598-017-03477-3","article-title":"Ohmyungsamycins promote antimicrobial responses through autophagy activation via AMP-activated protein kinase pathway","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.intimp.2026.116543_bb0145","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1021\/ol502472c","article-title":"Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces","volume":"16","author":"Khalil","year":"2014","journal-title":"Org. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00465-23","article-title":"Wollamide cyclic hexapeptides synergize with established and new tuberculosis antibiotics in targeting Mycobacterium tuberculosis","volume":"11","author":"Rollo","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.intimp.2026.116543_bb0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.peptides.2015.08.014","article-title":"Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity","volume":"73","author":"Ram\u00edrez-Carreto","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2026.116543_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00726-009-0449-y","article-title":"Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index","volume":"40","author":"Rodriguez","year":"2011","journal-title":"Amino Acids"},{"issue":"7","key":"10.1016\/j.intimp.2026.116543_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101742","article-title":"Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis","volume":"9","author":"Rodr\u00edguez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116543_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170626","article-title":"Novel antimicrobial cecropins derived from O. curvicornis and D. satanas dung beetles","volume":"145","author":"Henao Arias","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2026.116543_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170373","article-title":"B1CTcu5: A frog-derived brevinin-1 peptide with anti-tuberculosis activity","volume":"132","author":"Abraham","year":"2020","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.intimp.2026.116543_bb0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ni888","article-title":"Angiogenins: a new class of microbicidal proteins involved in innate immunity","volume":"4","author":"Hooper","year":"2003","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/antibiotics12010075","article-title":"In Vitro, In Vivo and In Silico Assessment of the Antimicrobial and Immunomodulatory Effects of a Water Buffalo Cathelicidin (WBCATH) in Experimental Pulmonary Tuberculosis","volume":"12","author":"Palacios","year":"2022","journal-title":"Antibiotics (Basel)."},{"issue":"8","key":"10.1016\/j.intimp.2026.116543_bb0190","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/AAC.00428-13","article-title":"Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7","volume":"57","author":"Pulido","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2026.116543_bb0195","series-title":"Unveiling the mode of action of human antimicrobial RNases against Mycobacterium tuberculosis using a surrogate macrophage infected model. TB Summit 2016. London","author":"Arranz-Trull\u00e9n","year":"2016"},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20062027","article-title":"Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses","volume":"205","author":"Yang","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.116543_bb0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1753425912446955","article-title":"The mammalian secreted RNases: mechanisms of action in host defence","volume":"19","author":"Gupta","year":"2013","journal-title":"Innate Immun."},{"key":"10.1016\/j.intimp.2026.116543_bb0210","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3389\/fimmu.2019.01500","article-title":"Human Antimicrobial RNases Inhibit Intracellular Bacterial Growth and Induce Autophagy in Mycobacteria-Infected Macrophages","volume":"10","author":"Lu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116543_bb0215","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbamem.2016.01.031","article-title":"Interaction between antimicrobial peptides and mycobacteria","volume":"1858","author":"Gutsmann","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2026.116543_bb0220","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.apjtm.2016.09.005","article-title":"Anti-tubercular peptides: a quest of future therapeutic weapon to combat tuberculosis","volume":"9","author":"Khusro","year":"2016","journal-title":"Asian Pac J Trop Med"},{"issue":"5386","key":"10.1016\/j.intimp.2026.116543_bb0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"issue":"Pt 3","key":"10.1016\/j.intimp.2026.116543_bb0230","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1042\/bj3440845","article-title":"Identification of an anti-mycobacterial domain in NK-lysin and granulysin","volume":"344","author":"Andreu","year":"1999","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.intimp.2026.116543_bb0235","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/pathogens9080655","article-title":"Coordinated in vitro release of granulysin, perforin and IFN-\u03b3 in TB and HIV\/TB co-infection associated with clinical outcomes before and after anti-TB treatment","volume":"9","author":"Pitabut","year":"2020","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/mdr.2009.0087","article-title":"Global reemergence of tuberculosis: are host defense peptides an option to ameliorate disease burden?","volume":"16","author":"Flores-Valdez","year":"2010","journal-title":"Microb. Drug Resist."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1399-3003.2000.16a20.x","article-title":"Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study","volume":"16","author":"Sharma","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2026.116543_bb0250","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1600-0609.1996.tb00714.x","article-title":"Antibiotic proteins of polymorphonuclear leukocytes","volume":"56","author":"Levy","year":"1996","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116543_bb0255","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/iai.64.3.926-932.1996","article-title":"In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis","volume":"64","author":"Miyakawa","year":"1996","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0260","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1038\/s41598-019-44256-6","article-title":"Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1","volume":"9","author":"Sharma","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116543_bb0265","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2018.12.076","article-title":"Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis","volume":"558","author":"Sharma","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0270","first-page":"179","article-title":"The role of cathelicidins in the innate host defenses of mammals","volume":"7","author":"Zanetti","year":"2005","journal-title":"Curr Issues Mol Biol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116543_bb0275","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1462-5822.2011.01644.x","article-title":"Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages","volume":"13","author":"Sonawane","year":"2011","journal-title":"Cell. Microbiol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb0280","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bbamem.2006.03.030","article-title":"LL-37, the only human member of the cathelicidin family of antimicrobial peptides","volume":"1758","author":"D\u00fcrr","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.intimp.2026.116543_bb0285","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1021\/acs.jnatprod.0c00194","article-title":"Production of Antitubercular Depsipeptides via Biosynthetic Engineering of Cinnamoyl Units","volume":"83","author":"Yang","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"18","key":"10.1016\/j.intimp.2026.116543_bb0290","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.3390\/ijms21186741","article-title":"Super-Resolution Microscopy Reveals a Direct Interaction of Intracellular Mycobacterium tuberculosis with the Antimicrobial Peptide LL-37","volume":"21","author":"Deshpande","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2026.116543_bb0295","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1007\/s11033-012-1997-x","article-title":"Cathelicidins: family of antimicrobial peptides","volume":"39","author":"Ko\u015bciuczuk","year":"2012","journal-title":"A review. Mol Biol Rep."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0300","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1099\/jmm.0.000912","article-title":"In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates","volume":"68","author":"Portell-Buj","year":"2019","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00430-024-00793-0","article-title":"Lysozyme: an endogenous antimicrobial protein with potent activity against extracellular, but not intracellular Mycobacterium tuberculosis","volume":"213","author":"Maier","year":"2024","journal-title":"Med. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0310","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/biom14040475","article-title":"Bactericidal Permeability-Increasing Protein (BPI) Inhibits Mycobacterium tuberculosis Growth","volume":"14","author":"Guzm\u00e1n-Beltr\u00e1n","year":"2024","journal-title":"Biomolecules"},{"issue":"14","key":"10.1016\/j.intimp.2026.116543_bb0315","article-title":"Delivery by Dendritic Mesoporous Silica Nanoparticles Enhances the Antimicrobial Activity of a Napsin-Derived Peptide Against Intracellular Mycobacterium tuberculosis","volume":"10","author":"Beitzinger","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0320","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/prot.25785","article-title":"Antimicrobial activity and structure of a consensus human \u03b2-defensin and its comparison to a novel putative hBD10","volume":"88","author":"Rodriguez","year":"2020","journal-title":"Proteins"},{"issue":"19","key":"10.1016\/j.intimp.2026.116543_bb0325","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1074\/jbc.RA118.006968","article-title":"A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities","volume":"294","author":"Yang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2026.116543_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059119","article-title":"Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models","volume":"8","author":"Rivas-Santiago","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0335","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"22","key":"10.1016\/j.intimp.2026.116543_bb0340","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1016\/j.bmcl.2011.09.031","article-title":"Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives","volume":"21","author":"Li","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2026.116543_bb0345","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tube.2018.10.008","article-title":"A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis","volume":"113","author":"Tenland","year":"2018","journal-title":"Tuberculosis (Edinb)."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0350","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/pharmaceutics15020540","article-title":"Mechanisms of a Mycobacterium tuberculosis Active Peptide","volume":"15","author":"Rao","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0355","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1038\/s41598-021-83755-3","article-title":"A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy","volume":"11","author":"Rao","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212858","article-title":"Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles","volume":"14","author":"Tenland","year":"2019","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.intimp.2026.116543_bb0365","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1021\/jm800495u","article-title":"Hunter-killer peptide (HKP) for targeted therapy","volume":"51","author":"Ellerby","year":"2008","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2026.116543_bb0370","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/pharmaceutics12111071","article-title":"antimicrobial peptide against Mycobacterium Tuberculosis that activates autophagy is an effective treatment for tuberculosis","volume":"12","author":"Pel\u00e1ez Coyotl","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2026.116543_bb0375","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jgar.2019.04.018","article-title":"Potent cationic antimicrobial peptides against Mycobacterium tuberculosis in vitro","volume":"19","author":"Silva","year":"2019","journal-title":"J Glob Antimicrob Resist."},{"key":"10.1016\/j.intimp.2026.116543_bb0380","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.tube.2014.08.001","article-title":"Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug resistant Mycobacterium tuberculosis","volume":"94","author":"Lan","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.intimp.2026.116543_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123960","article-title":"Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis","volume":"654","author":"Shao","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2026.116543_bb0390","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2015.07.001","article-title":"Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis","volume":"491","author":"Kwok","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.intimp.2026.116543_bb0395","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1128\/AAC.00175-13","article-title":"Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides","volume":"57","author":"Ram\u00f3n-Garc\u00eda","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb0400","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.biomaterials.2013.11.035","article-title":"Anti-mycobacterial activities of synthetic cationic \u03b1-helical peptides and their synergism with rifampicin","volume":"35","author":"Khara","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116543_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121097","article-title":"Antimicrobial activity of synthetic antimicrobial peptides loaded in poly-\u0190-caprolactone nanoparticles against mycobacteria and their functional synergy with rifampicin","volume":"608","author":"Sharma","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"25","key":"10.1016\/j.intimp.2026.116543_bb0410","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.2174\/138161211797416066","article-title":"Peptoids: bio-inspired polymers as potential pharmaceuticals","volume":"17","author":"Dohm","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb0415","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4161\/bbug.1.6.13642","article-title":"Gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs","volume":"1","author":"Carroll","year":"2010","journal-title":"Bioeng Bugs."},{"key":"10.1016\/j.intimp.2026.116543_bb0420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jconrel.2016.05.064","article-title":"Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment","volume":"235","author":"Silva","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0425","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1039\/D2TB01764D","article-title":"An intelligent peptide recognizes and traps Mycobacterium tuberculosis to inhibit macrophage phagocytosis","volume":"11","author":"Wang","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0430","doi-asserted-by":"crossref","first-page":"e00301","DOI":"10.1128\/mSphere.00301-17","article-title":"Lactoferricin peptides increase macrophages\u2019 capacity to kill Mycobacterium avium","volume":"2","author":"Silva","year":"2017","journal-title":"mSphere"},{"issue":"5","key":"10.1016\/j.intimp.2026.116543_bb0435","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41551-020-00665-x","article-title":"Pathogen-specific antimicrobials engineered de novo through membrane-protein biomimicry","volume":"5","author":"Simonson","year":"2021","journal-title":"Nat Biomed Eng."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0440","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01262-21","article-title":"Potentiating the Anti-Tuberculosis Efficacy of Peptide Nucleic Acids through Combinations with Permeabilizing Drugs","volume":"10","author":"Cotta","year":"2022","journal-title":"Microbiol. Spectrum"},{"issue":"8","key":"10.1016\/j.intimp.2026.116543_bb0445","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/jac\/dkw107","article-title":"Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability","volume":"71","author":"Khara","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"17","key":"10.1016\/j.intimp.2026.116543_bb0450","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1002\/cbic.202000163","article-title":"Synthesis and Biological Studies of Dodecameric Cationic Antimicrobial Peptides Containing Tetrahydrofuran Amino Acids","volume":"21","author":"Ghosh","year":"2020","journal-title":"Chembiochem"},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0455","doi-asserted-by":"crossref","first-page":"64","DOI":"10.31083\/j.fbl2702064","article-title":"Novel tetrameric cell penetrating antimicrobial peptoids effective against mycobacteria and drug-resistant Staphylococcus aureus","volume":"27","author":"Fleck","year":"2022","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2023.130415","article-title":"Membrane-active and DNA binding related double-action antimycobacterial mechanism of antimicrobial peptide W3R6 and its synthetic analogs","volume":"1867","author":"Wang","year":"2023","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0465","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/cbdd.13508","article-title":"Synthesis and biological activity of Ub2 derived peptides as potential host-directed antitubercular therapy","volume":"94","author":"Singh","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.intimp.2026.116543_bb0470","article-title":"Design of novel peptide inhibitors against the conserved bacterial transcription terminator","volume":"296","author":"Ghosh","year":"2021","journal-title":"Rho. J Biol Chem."},{"key":"10.1016\/j.intimp.2026.116543_bb0475","article-title":"Significance of LL-37 on Immunomodulation and Disease Outcome","volume":"2020","author":"Yang","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"25","key":"10.1016\/j.intimp.2026.116543_bb0480","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1039\/C6OB00800C","article-title":"Total synthesis of cyclomarins A, C and D, marine cyclic peptides with interesting anti-tuberculosis and anti-malaria activities","volume":"14","author":"Barbie","year":"2016","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0485","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1021\/acs.jmedchem.4c02351","article-title":"Generating a Peptide Library Using the Repeats of Amino Acid Scaffolds Created by Sliding the Framework of a 7-mer Human Chemerin Segment and Discovery of Potent Antibacterial and Antimycobacterial Peptides","volume":"68","author":"Akhtar","year":"2025","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2026.116543_bb0490","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/14786419.2010.539977","article-title":"Antimycobacterial activity of steroids, long-chain alcohols and lytic peptides","volume":"26","author":"Rugutt","year":"2012","journal-title":"Nat. Prod. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116543_bb0495","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.peptides.2011.03.002","article-title":"Membrane-active antimicrobial peptides and human placental lysosomal extracts are highly active against mycobacteria","volume":"32","author":"Jena","year":"2011","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0500","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00253-022-12306-1","article-title":"Production, characterization, and application of phage-derived PK34 recombinant anti-microbial peptide","volume":"107","author":"Wang","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0505","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/microorganisms12010177","article-title":"Redefining Peptide 14D: Substitutional Analysis for Accelerated TB Diagnosis and Enhanced Activity against Mycobacterium tuberculosis","volume":"12","author":"Hilpert","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.intimp.2026.116543_bb0510","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2026.116543_bb0515","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/cb1001558","article-title":"Describing the mechanism of antimicrobial peptide action with the interfacial activity model","volume":"5","author":"Wimley","year":"2010","journal-title":"ACS Chem. Biol."},{"issue":"41","key":"10.1016\/j.intimp.2026.116543_bb0520","doi-asserted-by":"crossref","first-page":"34120","DOI":"10.1074\/jbc.M112.359067","article-title":"Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic \u03b1-helical peptides","volume":"287","author":"Vermeer","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"42","key":"10.1016\/j.intimp.2026.116543_bb0525","doi-asserted-by":"crossref","first-page":"29180","DOI":"10.1074\/jbc.M109.018085","article-title":"Through the looking glass, mechanistic insights from enantiomeric human defensins","volume":"284","author":"Wei","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2026.116543_bb0530","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1128\/IAI.73.10.6332-6339.2005","article-title":"Conserved structure and function in the granulysin and NK-lysin peptide family","volume":"73","author":"Linde","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2026.116543_bb0535","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10989-011-9268-6","article-title":"A synthetic peptide derived from NK-lysin with activity against Mycobacterium tuberculosis and its structure\u2013function relationship","volume":"17","author":"Gu","year":"2011","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2026.116543_bb0540","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1074\/jbc.M111.303602","article-title":"Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions","volume":"287","author":"Yin","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2026.116543_bb0545","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/ar8000603","article-title":"N-methylation of peptides: a new perspective in medicinal chemistry","volume":"41","author":"Chatterjee","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.intimp.2026.116543_bb0550","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.phytochem.2011.07.014","article-title":"Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam","volume":"72","author":"Montaser","year":"2011","journal-title":"Phytochemistry"},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb0555","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.phytochem.2011.03.003","article-title":"Antiplasmodial and antimycobacterial cyclopeptide alkaloids from the root of Ziziphus mauritiana","volume":"72","author":"Panseeta","year":"2011","journal-title":"Phytochemistry"},{"issue":"23","key":"10.1016\/j.intimp.2026.116543_bb0560","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1021\/ja056780z","article-title":"Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-BSY0171, have a lasso structure","volume":"128","author":"Iwatsuki","year":"2006","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0565","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4062\/biomolther.2012.20.1.019","article-title":"Cyclic peptides as therapeutic agents and biochemical tools","volume":"20","author":"Joo","year":"2012","journal-title":"Biomol Ther (Seoul)."},{"issue":"21","key":"10.1016\/j.intimp.2026.116543_bb0570","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/bi900080d","article-title":"Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from (13)C, (31)P, and (19)F solid-state NMR","volume":"48","author":"Su","year":"2009","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.intimp.2026.116543_bb0575","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1128\/AAC.00585-12","article-title":"Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin","volume":"56","author":"Hansen","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2026.116543_bb0580","series-title":"Malaria. Available at","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.intimp.2026.116543_bb0585","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0145-305X(99)00015-4","article-title":"Antimicrobial peptides in insects: structure and function","volume":"23","author":"Bulet","year":"1999","journal-title":"Dev. Comp. Immunol."},{"issue":"25","key":"10.1016\/j.intimp.2026.116543_bb0590","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2174\/138161211797416057","article-title":"Antimalarial peptides: the long and the short of it","volume":"17","author":"Bell","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0595","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s13071-024-06450-y","article-title":"Leucinostatins from fungal extracts block malaria transmission to mosquitoes","volume":"17","author":"Niu","year":"2024","journal-title":"Parasit. Vectors"},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0600","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s13071-024-06608-8","article-title":"Leucinostatins target Plasmodium mitochondria to block malaria transmission","volume":"17","author":"Niu","year":"2024","journal-title":"Parasit. Vectors"},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0605","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbrc.2009.07.043","article-title":"AdDLP, a bacterial defensin-like peptide, exhibits anti-Plasmodium activity","volume":"387","author":"Gao","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2026.116543_bb0610","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/AAC.42.3.715","article-title":"The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite","volume":"42","author":"Rogers","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb0615","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/antibiotics11060801","article-title":"Antiplasmodial Cyclodecapeptides from Tyrothricin Share a Target with Chloroquine","volume":"11","author":"Leussa","year":"2022","journal-title":"Antibiotics (Basel)."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2026.116543_bb0620","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-5793(00)01384-3","article-title":"Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom","volume":"471","author":"Conde","year":"2000","journal-title":"FEBS Lett."},{"issue":"19","key":"10.1016\/j.intimp.2026.116543_bb0625","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1007\/s00018-008-8250-8","article-title":"Recombinant scorpine: a multifunctional antimicrobial peptide with activity against different pathogens","volume":"65","author":"Carballar-Lejaraz\u00fa","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0630","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.biochi.2010.01.011","article-title":"Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus","volume":"92","author":"Gao","year":"2010","journal-title":"Biochimie"},{"issue":"1\u20133","key":"10.1016\/j.intimp.2026.116543_bb0635","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.febslet.2004.07.019","article-title":"Isolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei","volume":"572","author":"Choi","year":"2004","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0640","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbapap.2009.12.017","article-title":"MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity","volume":"1804","author":"Zhu","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2026.116543_bb0645","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.peptides.2016.01.013","article-title":"Inhibition of malaria parasite Plasmodium falciparum development by crotamine, a cell penetrating peptide from the snake venom","volume":"78","author":"El Chamy","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2026.116543_bb0650","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/675985","article-title":"State of the art in the studies on crotamine, a cell penetrating peptide from South American rattlesnake","author":"Kerkis","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb0655","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/iai.57.9.2628-2633.1989","article-title":"Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes","volume":"57","author":"Gwadz","year":"1989","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.intimp.2026.116543_bb0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012652","article-title":"A novel broad-spectrum antibacterial and anti-malarial Anopheles gambiae Cecropin promotes microbial clearance during pupation","volume":"20","author":"Barreto","year":"2024","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb0665","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00436-019-06305-x","article-title":"The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum","volume":"118","author":"Tonk","year":"2019","journal-title":"Parasitol. Res."},{"issue":"15","key":"10.1016\/j.intimp.2026.116543_bb0670","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.molimm.2008.06.025","article-title":"Gene expression, antiparasitic activity, and functional evolution of the drosomycin family","volume":"45","author":"Tian","year":"2008","journal-title":"Mol. Immunol."},{"issue":"22","key":"10.1016\/j.intimp.2026.116543_bb0675","doi-asserted-by":"crossref","first-page":"12630","DOI":"10.1073\/pnas.221466798","article-title":"Gambicin: a novel immune responsive antimicrobial peptide from the malaria vector Anopheles gambiae","volume":"98","author":"Vizioli","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.intimp.2026.116543_bb0680","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0965-1748(95)00043-U","article-title":"Insect immunity: isolation of three novel inducible antibacterial defensins from the vector mosquito","volume":"25","author":"Lowenberger","year":"1995","journal-title":"Aedes aegypti. Insect Biochem Mol Biol."},{"issue":"29","key":"10.1016\/j.intimp.2026.116543_bb0685","doi-asserted-by":"crossref","first-page":"20092","DOI":"10.1074\/jbc.274.29.20092","article-title":"Antimicrobial activity spectrum, cDNA cloning, and mRNA expression of a newly isolated member of the cecropin family from the mosquito vector Aedes aegypti","volume":"274","author":"Lowenberger","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.intimp.2026.116543_bb0690","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.1073\/pnas.1003056107","article-title":"Blocking of Plasmodium transmission by cooperative action of Cecropin A and Defensin A in transgenic Aedes aegypti mosquitoes","volume":"107","author":"Kokoza","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.intimp.2026.116543_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003790","article-title":"Killer bee molecules: antimicrobial peptides as effector molecules to target sporogonic stages of Plasmodium","volume":"9","author":"Carter","year":"2013","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0700","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ttbdis.2018.03.011","article-title":"Antiplasmodial activity of tick defensins in a mouse model of malaria","volume":"9","author":"Couto","year":"2018","journal-title":"Ticks Tick Borne Dis."},{"key":"10.1016\/j.intimp.2026.116543_bb0705","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fmicb.2016.01682","article-title":"Antiplasmodial Activity Is an Ancient and Conserved Feature of Tick Defensins","volume":"7","author":"Cabezas-Cruz","year":"2016","journal-title":"Front. Microbiol."},{"issue":"43","key":"10.1016\/j.intimp.2026.116543_bb0710","doi-asserted-by":"crossref","first-page":"33464","DOI":"10.1074\/jbc.M001491200","article-title":"Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family","volume":"275","author":"Silva","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0715","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.exppara.2007.01.022","article-title":"Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp","volume":"116","author":"Moreira","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2026.116543_bb0720","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/cbic.201300034","article-title":"Cyclization of the Antimicrobial Peptide Gomesin with Native Chemical Ligation: Influences on Stability and Bioactivity","volume":"14","author":"Chan","year":"2013","journal-title":"ChemBioChem"},{"issue":"43","key":"10.1016\/j.intimp.2026.116543_bb0725","doi-asserted-by":"crossref","first-page":"13723","DOI":"10.1021\/bi9620621","article-title":"Membrane pores induced by magainin","volume":"35","author":"Ludtke","year":"1996","journal-title":"Biochemistry"},{"issue":"50","key":"10.1016\/j.intimp.2026.116543_bb0730","doi-asserted-by":"crossref","first-page":"31609","DOI":"10.1074\/jbc.272.50.31609","article-title":"Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis","volume":"272","author":"Ghosh","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.intimp.2026.116543_bb0735","doi-asserted-by":"crossref","first-page":"12416","DOI":"10.1021\/bi00164a017","article-title":"Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes","volume":"31","author":"Pouny","year":"1992","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb0740","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/AAC.44.9.2442-2451.2000","article-title":"Antimalarial activities of dermaseptin S4 derivatives","volume":"44","author":"Krugliak","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2026.116543_bb0745","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3389\/fphar.2019.01421","article-title":"Dermaseptins, Multifunctional Antimicrobial Peptides: A Review of Their Pharmacology, Effectivity, Mechanism of Action, and Possible Future Directions","volume":"10","author":"Bartels","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0750","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.exppara.2009.05.002","article-title":"Antiplasmodial and antileishmanial activities of phylloseptin-1, an antimicrobial peptide from the skin secretion of Phyllomedusa azurea (Amphibia)","volume":"123","author":"K\u00fcckelhaus","year":"2009","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0755","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.peptides.2004.11.002","article-title":"Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus","volume":"26","author":"Leite","year":"2005","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.intimp.2026.116543_bb0760","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2174\/092986609789353727","article-title":"Novel antimicrobial peptides isolated from skin secretions of the Mexican frog Hyla eximia","volume":"16","author":"Villa-Hern\u00e1ndez","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.intimp.2026.116543_bb0765","article-title":"Picturins and Pictuseptins, two novel antimicrobial peptide families from the skin secretions of the Chachi treefrog","volume":"264","author":"Mor\u00e1n-Marcillo","year":"2022","journal-title":"Boana picturata. J Proteomics."},{"issue":"8","key":"10.1016\/j.intimp.2026.116543_bb0770","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03339-23","article-title":"Bioactivity of synthetic peptides from Ecuadorian frog skin secretions against Leishmania mexicana, Plasmodium falciparum, and Trypanosoma cruzi","volume":"12","author":"Proa\u00f1o-Bola\u00f1os","year":"2024","journal-title":"Microbiol. Spectrum"},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb0775","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.chom.2012.10.017","article-title":"Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials","volume":"12","author":"Love","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb0780","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-3083.2009.02337.x","article-title":"Human gammadelta T cells produce the protease inhibitor and antimicrobial peptide elafin","volume":"70","author":"Marischen","year":"2009","journal-title":"Scand. J. Immunol."},{"issue":"36","key":"10.1016\/j.intimp.2026.116543_bb0785","doi-asserted-by":"crossref","first-page":"11570","DOI":"10.1021\/bi960900l","article-title":"Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution","volume":"35","author":"Tsunemi","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.intimp.2026.116543_bb0790","doi-asserted-by":"crossref","first-page":"42243","DOI":"10.1038\/srep42243","article-title":"The antimicrobial molecule trappin-2\/elafin has anti-parasitic properties and is protective in vivo in a murine model of cerebral malaria","volume":"7","author":"Roussilhon","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.116543_bb0795","doi-asserted-by":"crossref","DOI":"10.1038\/srep41772","article-title":"Involvement of \u03b2-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparum","volume":"7","author":"Terkawi","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0800","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/AAC.47.2.607-613.2003","article-title":"NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi","volume":"47","author":"Jacobs","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2026.116543_bb0805","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1128\/AAC.01342-07","article-title":"The antimicrobial peptide NK-2, the core region of mammalian nk-lysin, kills intraerythrocytic Plasmodium falciparum","volume":"52","author":"Gelhaus","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.intimp.2026.116543_bb0810","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1096\/fasebj.2.13.3049204","article-title":"In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi","volume":"2","author":"Jaynes","year":"1988","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0815","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1006\/expr.1995.1075","article-title":"Effect of a cecropin-like synthetic peptide (Shiva-3) on the sporogonic development of Plasmodium berghei","volume":"80","author":"Rodriguez","year":"1995","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2026.116543_bb0820","doi-asserted-by":"crossref","DOI":"10.1046\/j.1432-1327.1998.2570263.x","article-title":"Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei","volume":"257","author":"Boisbouvier","year":"1998","journal-title":"Eur. J. Biochem."},{"issue":"7","key":"10.1016\/j.intimp.2026.116543_bb0825","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1128\/AAC.46.7.2104-2110.2002","article-title":"Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias","volume":"46","author":"Arrighi","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0830","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1074\/jbc.M806201200","article-title":"Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides","volume":"284","author":"Mason","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"39","key":"10.1016\/j.intimp.2026.116543_bb0835","doi-asserted-by":"crossref","first-page":"11855","DOI":"10.1021\/bi000453g","article-title":"Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures","volume":"39","author":"Oh","year":"2000","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.intimp.2026.116543_bb0840","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.87.12.4761","article-title":"All-D amino acid-containing channel-forming antibiotic peptides","volume":"87","author":"Wade","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"135","key":"10.1016\/j.intimp.2026.116543_bb0845","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003515","article-title":"Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria","volume":"4","author":"Achtman","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb0850","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.chembiol.2010.07.007","article-title":"Structural studies of a peptide with immune modulating and direct antimicrobial activity","volume":"17","author":"Wieczorek","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.intimp.2026.116543_bb0855","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1475-2875-11-256","article-title":"Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides","volume":"11","author":"Kaushik","year":"2012","journal-title":"Malar. J."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0860","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijantimicag.2011.10.008","article-title":"In vitro antibacterial and antimalarial activity of dehydrophenylalanine-containing undecapeptides alone and in combination with drugs","volume":"39","author":"Sharma","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7","key":"10.1016\/j.intimp.2026.116543_bb0865","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/toxins11070379","article-title":"In Vitro and In Vivo Antimalarial Activity of LZ1, a Peptide Derived from Snake Cathelicidin","volume":"11","author":"Fang","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2026.116543_bb0870","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/microorganisms12030480","article-title":"Killing of Plasmodium Sporozoites by Basic Amphipathic \u03b1-Helical Fusion Peptides","volume":"12","author":"Aguirre-Botero","year":"2024","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0875","doi-asserted-by":"crossref","DOI":"10.1002\/psc.3296","article-title":"Net charge tuning modulates the antiplasmodial and anticancer properties of peptides derived from scorpion venom","volume":"27","author":"Pedron","year":"2021","journal-title":"J. Pept. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0880","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1128\/AAC.46.4.1059-1066.2002","article-title":"In vitro antiplasmodium effects of dermaseptin S4 derivatives","volume":"46","author":"Dagan","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.intimp.2026.116543_bb0885","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12192-017-0797-6","article-title":"Polymyxin B inhibits the chaperone activity of Plasmodium falciparum Hsp70","volume":"22","author":"Zininga","year":"2017","journal-title":"Cell Stress Chaperones"},{"issue":"12","key":"10.1016\/j.intimp.2026.116543_bb0890","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1021\/acs.biomac.0c01202","article-title":"Poly(N-vinylpyrrolidone) Antimalaria Conjugates of Membrane-Disruptive Peptides","volume":"21","author":"Jokonya","year":"2020","journal-title":"Biomacromolecules"},{"issue":"8","key":"10.1016\/j.intimp.2026.116543_bb0895","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/md21080434","article-title":"Anti-Protozoan Activities of Polar Fish-Derived Polyalanine Synthetic Peptides","volume":"21","author":"Nunes","year":"2023","journal-title":"Mar Drugs."},{"issue":"7","key":"10.1016\/j.intimp.2026.116543_bb0900","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00311-24","article-title":"Antimalarial activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes","volume":"68","author":"Lou","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.intimp.2026.116543_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108298","article-title":"Antimicrobial peptides selectively target malaria parasites by a cholesterol-dependent mechanism","volume":"301","author":"Kiper","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2026.116543_bb0910","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.peptides.2003.08.023","article-title":"The relationship between peptide structure and antibacterial activity","volume":"24","author":"Powers","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2026.116543_bb0915","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.bbamem.2008.06.007","article-title":"Toroidal pores formed by antimicrobial peptides show significant disorder","volume":"1178","author":"Sengupta","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2026.116543_bb0920","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10540-006-9030-z","article-title":"Melittin: a membrane-active peptide with diverse functions","volume":"27","author":"Raghuraman","year":"2007","journal-title":"Biosci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2026.116543_bb0925","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s10096-011-1233-y","article-title":"Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii","volume":"30","author":"L\u00f3pez-Rojas","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.intimp.2026.116543_bb0930","first-page":"157","article-title":"Antiparasitic peptides","volume":"135","author":"Pretzel","year":"2013","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb0935","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/pro.5560030902","article-title":"Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores","volume":"3","author":"Wimley","year":"1994","journal-title":"Protein Sci."},{"issue":"11","key":"10.1016\/j.intimp.2026.116543_bb0940","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/psc.698","article-title":"Antibacterial peptides and proteins with multiple cellular targets","volume":"11","author":"Otvos","year":"2005","journal-title":"J. Pept. Sci."},{"issue":"46","key":"10.1016\/j.intimp.2026.116543_bb0945","doi-asserted-by":"crossref","first-page":"32555","DOI":"10.1074\/jbc.274.46.32555","article-title":"Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets","volume":"274","author":"Castle","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.intimp.2026.116543_bb0950","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1007\/s00253-014-5792-6","article-title":"Insect antimicrobial peptides and their applications","volume":"98","author":"Yi","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"13","key":"10.1016\/j.intimp.2026.116543_bb0955","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1093\/nar\/gki725","article-title":"Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA","volume":"33","author":"Hsu","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"32","key":"10.1016\/j.intimp.2026.116543_bb0960","doi-asserted-by":"crossref","first-page":"27014","DOI":"10.1074\/jbc.R112.346098","article-title":"\u03b8-Defensins: cyclic peptides with endless potential","volume":"287","author":"Lehrer","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0965","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro2937","article-title":"Bacteriocins - a viable alternative to antibiotics?","volume":"11","author":"Cotter","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116543_bb0970","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1128\/iai.37.3.1093-1100.1982","article-title":"Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro","volume":"37","author":"Nickell","year":"1982","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb0975","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/jm400887j","article-title":"Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?","volume":"57","author":"Giordanetto","year":"2014","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2026.116543_bb0980","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb0985","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/bip.22250","article-title":"Peptide design for antimicrobial and immunomodulatory applications","volume":"100","author":"Haney","year":"2013","journal-title":"Biopolymers"},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb0990","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/biom8010004","article-title":"Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo","volume":"8","author":"Kumar","year":"2018","journal-title":"Biomolecules"},{"issue":"Pt 3","key":"10.1016\/j.intimp.2026.116543_bb0995","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/BJ20050520","article-title":"Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide","volume":"390","author":"Malina","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2026.116543_bb1000","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-981-13-3588-4_15","article-title":"Clinical Application of AMPs","volume":"1117","author":"Costa","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116543_bb1005","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/07388551.2020.1796576","article-title":"Antimicrobial peptides as therapeutic agents: opportunities and challenges","volume":"40","author":"Mahlapuu","year":"2020","journal-title":"Crit. Rev. Biotechnol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb1010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/pharmaceutics11090448","article-title":"Nanosystems as Vehicles for the Delivery of Antimicrobial Peptides (AMPs)","volume":"11","author":"Martin-Serrano","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2026.116543_bb1015","article-title":"Advanced delivery systems for peptide antibiotics. Adv Drug Deliv","volume":"197","author":"Cesaro","year":"2023","journal-title":"System"},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb1020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/0929866525666181026160852","article-title":"Antimicrobial Peptides: Recent insights on biotechnological interventions and future perspectives","volume":"26","author":"Sinha","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.intimp.2026.116543_bb1025","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70072","article-title":"AI Methods for Antimicrobial Peptides: Progress and Challenges","volume":"18","author":"Brizuela","year":"2025","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.intimp.2026.116543_bb1030","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400579","article-title":"Machine Learning \u2013Assisted prediction and generation of antimicrobial peptides","volume":"5","author":"Bhangu","year":"2025","journal-title":"Small Sci."},{"issue":"9","key":"10.1016\/j.intimp.2026.116543_bb1035","article-title":"Mechanism-driven screening of membrane-targeting and pore-forming antimicrobial peptides","volume":"13","author":"Li","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.intimp.2026.116543_bb1040","doi-asserted-by":"crossref","first-page":"41082","DOI":"10.1021\/acsomega.2c04465","article-title":"iAMAP-SCM: A novel computational tool for large scale identification of antimalarial peptides using estimated propensity scores of dipeptides","volume":"7","author":"Charoenkwan","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.intimp.2026.116543_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102733","article-title":"Artificial intelligence-driven antimicrobial peptide discovery","volume":"83","author":"Szymczak","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.intimp.2026.116543_bb1050","article-title":"Predicting antimicrobial peptide activity: a machine learning-based quantitative structure\u2013activity relationship approach","volume":"17(8):993","author":"Bonifacio-Velez de Villa","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2026.116543_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116709","article-title":"The role and future prospects of artificial intelligence algorithms in peptide drug development","volume":"175","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"48","key":"10.1016\/j.intimp.2026.116543_bb1060","doi-asserted-by":"crossref","first-page":"46779","DOI":"10.1074\/jbc.M207587200","article-title":"RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin","volume":"277","author":"Harder","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb1065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1432-1033.1996.0325z.x","article-title":"The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes","volume":"238","author":"Gudmundsson","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"35","key":"10.1016\/j.intimp.2026.116543_bb1070","doi-asserted-by":"crossref","first-page":"14972","DOI":"10.1073\/pnas.0904465106","article-title":"Selective reciprocity in antimicrobial activity versus cytotoxicity of hBD-2 and crotamine","volume":"106","author":"Yount","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb1075","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1432-1033.1995.694_2.x","article-title":"Metchnikowin, a novel immune-inducible proline-rich peptide from Drosophila with antibacterial and antifungal properties","volume":"233","author":"Levashina","year":"1995","journal-title":"Eur. J. Biochem."},{"issue":"5","key":"10.1016\/j.intimp.2026.116543_bb1080","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/AAC.05180-14","article-title":"Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria","volume":"59","author":"P\u00f6ppel","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"20","key":"10.1016\/j.intimp.2026.116543_bb1085","doi-asserted-by":"crossref","first-page":"14893","DOI":"10.1016\/S0021-9258(18)82417-6","article-title":"A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution","volume":"268","author":"Bulet","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb1090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.dci.2015.08.001","article-title":"Ixodes ricinus defensins attack distantly-related pathogens","volume":"53","author":"Tonk","year":"2015","journal-title":"Dev. Comp. Immunol."},{"issue":"15","key":"10.1016\/j.intimp.2026.116543_bb1095","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1073\/pnas.84.15.5449","article-title":"Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor","volume":"84","author":"Zasloff","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"50","key":"10.1016\/j.intimp.2026.116543_bb1100","doi-asserted-by":"crossref","first-page":"31635","DOI":"10.1016\/S0021-9258(18)31742-3","article-title":"The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms","volume":"269","author":"Mor","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116543_bb1105","first-page":"1","article-title":"Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog","volume":"146","author":"Proa\u00f1o-Bola\u00f1os","year":"2016","journal-title":"Cruziohyla calcarifer. J Proteomics."},{"issue":"6","key":"10.1016\/j.intimp.2026.116543_bb1110","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00726-021-02986-w","article-title":"Novel antimicrobial cruzioseptin peptides extracted from the splendid leaf frog","volume":"53","author":"Cuesta","year":"2021","journal-title":"Cruziohyla calcarifer. Amino Acids."},{"issue":"8","key":"10.1016\/j.intimp.2026.116543_bb1115","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/j.1460-2075.1995.tb07150.x","article-title":"NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity","volume":"14","author":"Andersson","year":"1995","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb1120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41551-021-00801-1","article-title":"Mining for encrypted peptide antibiotics in the human proteome","volume":"6","author":"Torres","year":"2022","journal-title":"Nat Biomed Eng."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb1125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0014-5793(92)80377-S","article-title":"Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity","volume":"296","author":"Andreu","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.intimp.2026.116543_bb1130","first-page":"259","article-title":"Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids","author":"Boman","year":"1989","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.intimp.2026.116543_bb1135","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/ph6121543","article-title":"Antimicrobial Peptides","volume":"6","author":"Bahar","year":"2013","journal-title":"Pharmaceuticals"},{"issue":"14","key":"10.1016\/j.intimp.2026.116543_bb1140","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.3390\/molecules27144325","article-title":"Membrane Permeabilization and Antimicrobial Activity of Recombinant Defensin-d2 and Actifensin against Multidrug-Resistant Pseudomonas aeruginosa and Candida albicans","volume":"27","author":"Gbala","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb1145","first-page":"48","article-title":"Antimicrobial peptides: mechanism of action, activity and clinical potential","volume":"8","author":"Zhang","year":"2021","journal-title":"Mil Med Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.116543_bb1150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016968","article-title":"Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model","volume":"6","author":"Torrent","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116543_bb1155","volume":"19","author":"Phuong","year":"2024","journal-title":"Chem. Med. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2026.116543_bb1160","first-page":"26438","article-title":"Exploratory data analysis of physicochemical parameters of natural antimicrobial and anticancer peptides: Unraveling the patterns and trends for the rational design of novel peptides","volume":"14","author":"Saini","year":"2024","journal-title":"Bioimpacts"},{"issue":"5","key":"10.1016\/j.intimp.2026.116543_bb1165","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.01148-10","article-title":"Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial peptides","volume":"55","author":"Ross","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2026.116543_bb1170","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.715246","article-title":"Ab initio Designed Antimicrobial Peptides against Gram-Negative Bacteria","volume":"12","author":"Bobde","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.116543_bb1175","doi-asserted-by":"crossref","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: The Antimicrobial Peptide Database as a Tool for Research and Education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.116543_bb1180","doi-asserted-by":"crossref","first-page":"D488","DOI":"10.1093\/nar\/gkab651","article-title":"DRAMP 3.0: An Enhanced Comprehensive Data Repository of Antimicrobial Peptides","volume":"50","author":"Shi","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:10:04Z","timestamp":1777129804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926003887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":236,"alternative-id":["S1567576926003887"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116543","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial peptides in malaria and tuberculosis management: a systematic review of emerging evidence","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116543"}}